@SofinnovaVC Profile picture

Sofinnova Partners

@SofinnovaVC

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability.

Similar User
Seventure Partners photo

@SeventureP

5AM Ventures photo

@5amVentures

Labiotech.eu photo

@Labiotech_eu

@Elaia_Partners photo

@Elaia_Partners

Medicxi photo

@medicxi

Flagship Pioneering photo

@FlagshipPioneer

OrbiMed photo

@OrbiMed

Frst photo

@frst_vc

European Biotech photo

@EuroBiotechNews

Omnes Capital photo

@OmnesCapital

France Biotech photo

@FranceBiotech

Ventech photo

@Ventech_VC

Atlas Venture photo

@atlasventure

IRDI Capital Investissement photo

@IrdiCapital__I

Rafaele Tordjman photo

@RafaeleTordjman

Congratulations to BrightHeart, a @SofinnovaVC MD Start portfolio company on its FDA 510(k) clearance for its first artificial intelligence software, designed to transform prenatal ultrasound evaluations of the fetal heart. 🔗Learn more: sofinnovapartners.com/news/brighthea…

Tweet Image 1

Sofinnova Partners Reposted

Thank you to everyone who joined the 𝐇𝐓𝐁𝐂 𝐓𝐞𝐜𝐡𝐁𝐢𝐨 breakfast, hosted in collaboration with @SofinnovaVC In this quarterly session our healthcare investor, @l3ighbrody led a stellar panel to discuss the future of healthcare, biotech, and investment. With Simon Turner…

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Congratulations to @InventivaPharma, a @SofinnovaVC Crossover portfolio company, on its successful €348 million raise, making it the largest fundraising by a #biotech specializing in drug development in France. Learn more: sofinnovapartners.com/news/inventiva… #financing #drugdevelopment

Tweet Image 1

We’re pleased to welcome our Head of Human Resources at @SofinnovaVC This appointment reaffirms our unwavering commitment to strengthening the strong, inclusive culture that has been central to the our success for the past 50+ years. Learn more: sofinnovapartners.com/news/sofinnova…

Tweet Image 1

We’re delighted to have led the oversubscribed $105 million Series B fundraising round for Purespring Therapeutics and to welcome them as a @SofinnovaVC portfolio company. Learn more: hubs.ly/Q02STR9C0

Tweet Image 1

Sofinnova Partners Reposted

Moon Surgical is a finalist for the 2024 Pantheon Awards by California Life Sciences! 🎉 We’re honored to be recognized in the Convergent Technologies (MedTech, Digital & Diagnostic) category, highlighting our commitment to innovation at the intersection of technology and…

Tweet Image 1

Congratulations to Genespire a @SofinnovaVC portfolio company, on its oversubscribed Series B fundraising round. Learn more: hubs.ly/Q02R2nLq0

Tweet Image 1

Congratulations to AAVantgarde, a @SofinnovaVC Telethon Strategy portfolio company, on dosing its first patient in the LUCE-1 trial, assessing the safety and tolerability of AAVB-081 for the treatment of retinitis pigmentosa related to USH1B. Learn more: hubs.ly/Q02PXJ2W0

Tweet Image 1

Congratulations to @Nova_Meat, a @SofinnovaVC Industrial Biotech portfolio company, on its oversubscribed Series A round. Learn more: hubs.ly/Q02PFT3P0

Tweet Image 1

We’re pleased to welcome a new Partner in the @SofinnovaVC Capital Strategy, our early-stage investment strategy, established 35 years ago. Learn more: hubs.ly/Q02Phgbx0 #newhire #leadership #biotechnology #investinginthefuture

Tweet Image 1

@BiotechTV kicked off their European tour in Paris with an overview of the European #biotech landscape with Sofinnova Partners' Chairman and Managing Partner. They discussed the capital markets, hidden gems of innovation, the start up scene in the EU vs the US, and more.

From Paris: With decades of experience, @SofinnovaVC's Chairman and Managing Partner Antoine Papiernik shares his thoughts on investing in life sciences and Europe. Full video: biotechtv.com/post/sofinnova…



Congratulations to HEPTA Medical, a @SofinnovaVC MD Start portfolio company, on the first close of its Series A round. Learn more: hubs.ly/Q02NyY130 #medtech #lungcancer #SeriesA

Tweet Image 1

👏It's official: The @Calliditas1 team is now part of the Asahi Kasei team. This acquisition reaffirms the @SofinnovaVC Crossover’s strategy and the pharmaceutical industry’s appetite for late-stage assets. Learn more: hubs.ly/Q02Nk4_M0

Tweet Image 1

Sofinnova Partners Reposted

We're kicking off the LSI Europe '24 Welcome Reception with a Fireside Chat featuring @joshatstanford and @antoinepapiern1 at 7:00 pm on Monday, September 16th in #Sintra, #Portugal. Josh Makower joined the @SofinnovaVC team in January 2024 as an Advisory Venture Partner. As…

Tweet Image 1

Sofinnova Partners Reposted

In this episode of the #DeviceTalksWeekly Podcast, Host Tom Salemi delves into the opportunities in #Women’sHealth devices with @SofinnovaVC Managing Partner Antoine Papiernik and May Health CEO Anne Morrissey. LISTEN HERE: devicetalks.com/may-health-vc-… #PCOS #OvarianHealth

Tweet Image 1

Congratulations to @micropep a @SofinnovaVC Industrial Biotech portfolio company, on its Series B financing and launch of its proprietary discovery platform, Krisalix. Learn more: hubs.ly/Q02HXST10 #impactinvesting #agbiotech #SeriesB

Tweet Image 1

Congratulations to @deepchealth, a @SofinnovaVC portfolio company, on the close of its financing round. We’ve been lead investors in deepc since the first tranche of their Series A round. Learn more: hubs.ly/Q02HVV930 #digitalmedicine #ai

Tweet Image 1

Congratulations to Elicit Plant, a @SofinnovaVC Industrial Biotech portfolio company, on its partnership with @Bayer France. The partnership between Elicit Plant and Bayer is aimed at accelerating maize resilience in France. Learn more: hubs.ly/Q02HqLDC0

Tweet Image 1

Congratulations to @asceneuron_sa a @SofinnovaVC portfolio company, on its oversubscribed Series C financing of $100M. The recently raised capital will be used to advance their lead asset ASN51 into Ph. 2 for the treatment of Alzheimer’s. Learn more: hubs.ly/Q02GHWzN0

Tweet Image 1

Congratulations to Myricx Bio a @SofinnovaVC portfolio company on its £90m series A financing. this achievement further strengthens our conviction and our commitment to supporting the team. Learn more: hubs.ly/Q02FxHKV0 #ADCs #CancerTreatment #SeriesA

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.